NSE: HINDUNILVR· FMCGCore · Aug 26Large cap

Hindustan Unilever

Broadest lever on the volume recovery

Last close
₹1,863.80
29 Sept 2026 · reference
1D · 1M
−1.7% · −7.3%
price-only
Weight
3.3%
31 Jul 2026 · Aug rank 9
Thesis review
8 Sep 2026
Why We Own, p32
Coverage owner: Research (per book); latest results Q Jun-26Screener ↗Tijori ↗NSE ↗
What the business is

Approved description

India's largest FMCG company (Unilever subsidiary) selling home care (Surf, Rin, Vim), beauty & wellbeing (Dove, Lakme, Ponds), personal care (Lifebuoy, Lux, Closeup) and foods (Horlicks, Kissan, Knorr, Bru) through ~9 million retail outlets. FY26 consolidated revenue was Rs 64,468 cr with 23-24% EBITDA margin; the ice-cream business (Kwality Wall's) was demerged and listed separately on 16-Feb-2026. Market-share leadership in most categories it operates in (company claims ~9 of 10 Indian households use an HUL brand); exact category shares not disclosed in sources used.

Why we own it · 5 approved reasons
  1. 01Volume inflection: underlying volume growth rose from 2-4% through FY25-H1FY26 to 6% in Q4FY26 and 5% in Q1FY27 with USG of 10%, the best in 13 quarters (HUL Q1FY27 release via Business Standard 28-Jul-2026).
  2. 02Portfolio reshaped for growth: Home Care +14% and Beauty & Wellbeing +12% USG in Q1FY27; ice cream (low-margin) demerged in Feb-2026; Rs 2,000 cr capex for capacity (ICICI Direct May-2026).
  3. 03Cash machine: almost debt-free (borrowings Rs 1,478 cr vs equity ~Rs 48,700 cr), 92% dividend payout, FY26 dividend Rs 41/share (Rs 19 interim + Rs 22 final, total payout Rs 9,633 cr), 2.1% yield.
  4. 04Valuation at the low end of its own range: ~42x FY27E ICICI Direct EPS and 9.5x book vs Nestle India at 73x trailing; consensus targets Rs 2,460-2,800 imply 25-43% upside from Rs 1,960.
  5. 05Macro tailwinds: GST 2.0 (22-Sep-2025) cut toothpaste, soaps, shampoos and many foods from 18%/12% to 5% (~60% of FMCG basket repriced per NIQ) and ~Rs 1.7 lakh cr/yr of state cash transfers to ~120 mn women support mass-market demand.
Full thesis, sizing and review history →
Price

Reference close, with results-period markers

HINDUNILVR
Close as of 29 Sept 2026
  1. 1Q Sep-25 end · 30 Sept 2025
  2. 2Q Dec-25 end · 31 Dec 2025
  3. 3Q Mar-26 end · 31 Mar 2026
  4. 4Q Jun-26 end · 30 Jun 2026
Yahoo Finance chart API (unlicensed reference data; not for redistribution). Price-only series (split-adjusted; dividends excluded). Gaps are non-trading days.
1D
−1.7%
28 Sept 2026
1W
−3.6%
22 Sept 2026
1M
−7.3%
28 Aug 2026
3M
−13.4%
29 Jun 2026
6M
−10.2%
27 Mar 2026
1Y
−25.4%
29 Sept 2025
Buoyant Screener

Quality score, technicals and Buoyant Score

Value it →

Computing the scorecard…

Results centre

Latest quarter · Q Jun-26

Latest quarter versus prior year and prior quarter
Line (₹ cr)Q Jun-26YoYQoQ
Net Sales17,341+10.1%+6.1%
Operating Profit3,947+8.4%+2.8%
Net Profit2,673−3.0%−10.7%
Implication for thesisBroadly unchanged · per 8 Sep 2026 reviewQ1FY27 (Jun-26): revenue 17,341 (+10.1% YoY), PAT 2,680 (-3.2%)

Reported vs internal estimate: internal quarterly estimates are not in the supplied package; consensus feed not licensed. YoY/QoQ per PRD §12.5 (transitions, not %, on non-positive bases).

Key facts

Position and valuation context

3.3%
Weight, 31 Jul 2026
Aug rank 9 · Core
₹4.95 L cr
Market cap, July 2026 research sheet
Tijori latest: 4.55 L Cr
46.2x
P/E FY27E · Buoyant
FY28E 44.1x
21.3%
ROE FY27E · Buoyant
FY28E 23.0%
30.4x
P/E trailing (Tijori)
30.86%
ROE latest FY (Tijori)
ROCE 22.55%

General industrial/consumer/IT preset: growth, margins, ROCE/ROIC, working capital, FCF, net debt; P/E, EV/EBITDA.

Street view · 2 reports
All broker research →
Target (median)
₹2,214
range ₹2,214 – ₹2,503
Implied vs 29 Sept 2026
+18.8%
on ₹1,863.8 reference close
Ratings
1/1/0
buy / neutral / sell · latest 19 Aug 2026

Sell-side targets are third-party views, not Buoyant's; the upside is recomputed on our reference close, so it differs from the figure printed at the broker's price date.

Investment case and valuation

Valuation range

No headline target on this page; the book quotes the thesis and the risk rather than a target.

₹1,960
Price (2026-09-07)
46.2x / 44.1x
FY27E / FY28E P/E (Buoyant sheet)
21.3%
FY27E ROE (Buoyant sheet)
41.8x
Trailing P/E
9.4x
Price / book
11%
EPS CAGR FY26–28E
Assumptions, sensitivity, scenarios →
Next catalysts · material risks

What we watch

Catalysts
  • Q2FY27 results (late Oct-2026): first quarter fully lapping GST 2.0 base effects; watch for UVG holding at 5%+ and margin recovery from pricing actions.
  • Kwality Wall's open offer by Magnum Ice Cream Co consortium (26% of voting capital) post 16-Feb-2026 listing - completion cleans up HUL's portfolio narrative.
  • Festive-season demand (Oct-Nov 2026) supported by state cash transfers and lower GST; interim dividend typically announced with Q2 results.
Key risks
  • Commodity inflation: 8-10% material cost inflation in Q1FY27 (palm oil, crude derivatives) with management expecting 2-5% sequential inflation and only 'calibrated' pricing - EBITDA margin risk to the 22.7% FY27E.
  • Personal Care (largest legacy segment) grew only 4% USG in Q1FY27 and is losing share to small/regional players that NIQ shows outgrowing large manufacturers.
  • Structural growth ceiling: 5-yr sales CAGR only 6.5% (screener); at 42x forward PE, any slippage back to low-single-digit volumes drives further de-rating (stock already -13% from May-26 levels).
Sources: · fundamentals Tijori Finance (company filings), pulled locally via MCP batch; not licensed for redistribution · prices Yahoo Finance chart API (unlicensed reference data; not for redistribution).